Enasidenib uses and prices

Enasidenib (Enasidenib) is an oral treatment for the treatment of adult patients with relapsed or refractory (R/R)acute myeloid leukemia (AML). Acute myeloid leukemia is a rapidly growing cancer that forms in the bone marrow and causes an increase in the number of abnormal white blood cells in the blood and bone marrow. Doctors select patients who qualify for this treatment by testing their blood or bone marrow for the presence of IDH2 mutations. Ensiidi plain investigational medicine is not currently on the market in the country, nor is it covered by medical insurance. The price of ensidipine plain medicine when it is launched overseas is very high, and the price of each box may be around 30,000 yuan (the price may fluctuate due to the exchange rate).